At Altratech, our mission is to enable next generation molecular detection.
This exciting technology enables robust, straightforward and flexible molecular diagnostics in any environment.
At Altratech, our mission is to enable next generation molecular detection.
This exciting technology enables robust, straightforward and flexible molecular diagnostics in any environment.
KeyChain PNA
Altratech uses PNA Technology to address the fundamental complication of extracting genetic material from a biological sample. KeyChain PNA offers a purely synthetic alternative to biotinylation; it is reversible, tuneable, and programmable. KeyChain PNA will enable users to both multiplex and simplify sample preparation applications in a way which is not currently possible.
BioSensing
At Altratech, we use fringe-field capacitive sensing to quantify molecular targets. These sensors which sit in the top layer of a standard CMOS chip, detect the beads (magnetic, non-magnetic, gold, or silver nanoparticles) associated with a target. The surface of the sensor is also functionalised with PNA technology to enable multiplexing and robust detection.
Detection by Proxy
Any Person. Anywhere. Any Sample.
Altratech – Next Generation Molecular Detection
About Altratech
We are a team of seventeen scientists and engineers (molecular biology, surface chemistry, microfluidics, and chip design) bringing together nano biotechnology, chemistry, and semiconductors to radically change the accessibility of high content genetic data. We have been working together since 2016 on the development of this ground-breaking science
We are creating an infrastructure of technology and data to manage contagious viral diseases, important for the future of decentralised connected healthcare and wellbeing.
Based on the novel Detection by Proxy concept, Altratech has developed the next generation of molecular detection. The technology enables any person, anywhere, to rapidly and accurately measure and quantify viral RNA, DNA, antigen, or antibody samples.
In the News
Altratech completes HIV study with CUH, secures €3.5M funding to advance its novel technology to clinical trials
Altratech is developing a portable RNA kit, a device capable of diagnosing viruses such as HIV, Ebola and zika without the need for a lab.
Altratech presents at NextGenDx 2020
At NextGenDx conference (Aug 2020), Altratech presented “Novel Techniques for POC Disease Monitoring Utilizing Programmable Molecular Velcro” These advanced PNA probes were co-developed by Altratech and NIH, and jointly filed in a US patent disclosure
Altratech selected as a top-25 Medtech Showcase Accelerator startup
MedTech Innovator Selects 50 Best-in-Class Startups for 2019 Showcase and Accelerator
